AstraZeneca has set an ambitious target to deliver $80 billion in revenue by 2030

Worldwide revenue (in millions USD) for the second quarter (Q2) of 2025, the first half (H1) of 2025, and 2024 for the top 10 of AstraZeneca's marketed drugs.

(Please use a modern browser to see the interactive version of this visualization)

Chart: © Phalguni Deswal, Drug and Device World (www.druganddeviceworld.com)Source: AstraZeneca's financial disclosuresGet the dataDownload imageCreated with Datawrapper